Contact Information

Business Office

C. Warren Olanow, M.D., FRCPC is the
Henry P. and Georgette Goldschmidt Professor and Chairman Emeritus of the
Department of Neurology, and Professor in the Department of Neuroscience at the
Mount Sinai School of Medicine in New York City.

He received his medical degree from
the University of Toronto, performed his neurology training at the New York
Neurological Institute at Columbia Presbyterian Medical Center at Columbia
University, and did post-graduate studies in neuroanatomy at Columbia
University. He served on the faculties of McGill University, Duke University,
and the University of South Florida prior to joining Mount Sinai.

He is Past President of the Movement
Disorder Society, Past President of the International Society of Motor
Disturbances and Past Treasurer of the American Neurological Association. He
has been named an Honorary Professor at the University of London (Royal Free
Hospital), an Honorary Member of the French Neurological Society, an honorary
fellow of the Royal College of Physicians of the United Kingdom (FRCP (hon), was
the recipient of the Presidential Award from the Movement Disorder Society, and
was the recipient of the Movement
Disorder Research Award from the American Academy of Neurology. He serves on
the Board of Directors of the National Space Biomedical Research Institute, is a
member of the executive committee of the Michael J Fox Foundation Scientific Advisory
Board, is the past Chairman of the Scientific Advisory Board of the
Bachmann-Strauss Foundation and has served on numerous additional medical and scientific
advisory boards. He has served on several editorial boards including as Editor-in-Chief
of the journal Movement Disorders.

His clinical and basic science research
efforts are directed toward defining more effective therapies for Parkinson’s
disease and other neurodegenerative disorders. Dr. Olanow has authored more than 350
publications, and was ranked #1 in the United States in citations for
Parkinson’s disease during the past quarter century. He has lectured on movement
disorders at Universities and Conferences throughout the world.

Clinical Focus

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical,
device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs.
In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching,
Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Olanow during 2015 and/or 2016.
Please note that this information may differ from information posted on corporate sites due to timing or classification differences.